40 clinical trials matched your search for Pancreatic Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Pancreatic Cancer The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) Fay Kastrinos, MD
Pancreatic Cancer Study of Multiple Treatment Combinations in Patients with Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) Gulam Manji, MD, PhD
Pancreatic Cancer Study of Drug in Patients with Advanced Pancreatic Cancer After Failure of First-Line Therapy Ruth White, MD, PhD
Pancreatic Cancer Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery Susan Bates, MD
Pancreatic Cancer Precision Oncology in Advanced Pancreatic Cancer Gulam Manji, MD, PhD
Pancreatic Cancer Study to Evaluate AB680 Combination Therapy in Participants with Gastrointestinal Malignancies Gulam Manji, MD, PhD
Pancreatic Cancer Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma Gulam Manji, MD, PhD
Pancreatic Cancer Registry Study to Evaluate the Nanoknife System in Treating Stage 3 Pancreatic Adenocarcinoma Michael Kluger, MD, MPH
Pancreatic Cancer Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for Locally Advanced Pancreatic Cancer (TIGeR-PaC) Susan Bates, MD
Pancreatic Cancer Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer Susan Bates, MD
Pancreatic Cancer Study of Drug - SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) Gulam Manji, MD, PhD
Cancer Molecular Analysis for Therapy Choice (MATCH) Richard Carvajal, MD
Cancer Study of IDE196 in Patients with Solid Tumors Richard Carvajal, MD
Cancer Study of BA3011 in Subjects with Advanced Solid Tumors Matthew Ingham, MD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Cancer A Study in Subjects With Advanced Cancer Richard Carvajal, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Cancer Smartphone App for Cancer Medication Adherence Melissa Accordino, MD
Cancer Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors Richard Carvajal, MD
Cancer COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors Benjamin Izar, MD
Cancer LYT-200 Alone and in Combination With Chemotherapy or Anti-PD-1 in Patients With Metastatic Solid Tumors Gulam Manji, MD, PhD
Cancer A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Cancer Benjamin Izar, MD
Cancer Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of IV Contrast on Patients Going Through Image Guided Radiation Therapy (IGRT) for Abdominal and Pelvic Cancer David Horowitz, MD
Cancer Study of New Oral Anti-Cancer Drug (OACD) Dawn Hershman, MD
Cancer Study of MPT-0118 Alone or in Combination with Keytruda in Patients with Advanced or Metastatic Cancer Shaheer Khan, DO
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD
Cancer Study of INCB106385 Alone or in Combination with INCMGA00012 in Patients with Advanced Cancer Mark Stein, MD
Cancer Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer Benjamin Herzberg, MD
Cancer Study of Ulixertinib (BVD-523) for Patients with Advanced Cancer that Show Genetic Alterations Richard Carvajal, MD
Cancer Study of IDE397 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD
Cancer Study of RP-6306 in Combination with Gemcitabine (Chemotherapy) for Patients with Advanced Solid Tumors Ryan Moy, MD
Cancer Study of CS5001 in Patients with Advanced Solid Tumors Richard Carvajal, MD
Cancer Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation Benjamin Herzberg, MD
Cancer Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer Ryan Moy, MD
Cancer Study of E-602 Alone or in Combination with Keytruda (Pembrolizumab) in Patients with Advanced Cancer Brian Henick, MD
Cancer Study of SHR-A1904 in Patients with Advanced Solid Tumors Ryan Moy, MD
Cancer Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer Brian Henick, MD
Cancer Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer Gary Schwartz, MD
Cancer Study of RMC-6291 in Patients with Advanced Solid Tumors Benjamin Herzberg, MD